利记·sbobet(中国)-唯一官方网站

En

中文简体

中文繁体

Our Company

Back

Our Company

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China

About Company
Leadership
Honor
Brand Culture
Member Companies

Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.
Our Business

Back

Our Business

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

Pharmaceutical Manufacturing
Vaccines
Medical Devices
Medical Diagnosis
Healthcare Services
Pharmaceutical Distribution And Retail

Fosun Pharma is patient-centered and clinical needs-oriented. The company enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. Fosun Pharma also vigorously explores cutting-edge technologies, such as RNA, oncolytic viruses, gene therapy and PROTAC, to enhance its innovation capabilities.
R&D

Back

R&D

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

Global R&D Center
R&D Pipeline
Innovation Platform
Clinical Development
R&D News

Guided by innovation and internationalization, the company continuously enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.
ESG

返回

ESG

*data from: Fosun Pharma 2024 ESG and Sustainability Report

Governance Excellence
Access to Healthcare
Quality First
Green Environment
Sustainable Supply
Talent Development
Fosun Pharma Health Care Fund
ESG Report Download
CSR News

SBOBET利记官网医药集团将可持续发展纳入公司整体发展战略，重视ESG长效治理能力，建立了由董事会监管、ESG委员会实施、ESG工作小组执行的三级ESG治理架构。董事会ESG委员会负责制定并推进本集团ESG愿景、目标、策略，并向董事会提供建议；ESG工作小组负责梳理拟订重要ESG议题，拟订可持续发展量化目标并跟踪达成进度。ESG委员会和ESG工作小组致力于将ESG理念融入企业运营，提升企业可持续发展能力。
Investor Relations

Back

Investor Relations

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

Announcements
Corporate Governance
Financial Report
Investor Presentation Materials
FAQS
Investor Contact
Dissemination of Corporate Communications by Electronic Means

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
News

Back

News

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

Press Release
Member Companies News
Media Resources
Media Contact

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
Careers

Back

Careers

Some top talent with strong entrepreneurship gathers here with us.

Talent Concept
Incentives
Life At Fosun Pharma

We are looking for people that recognize and practice our cultural values, and can learn fast to create continuous value; possess profound professional knowledge of the industry, a wide vision of different regions, and global-level expertise in a certain field. We will also be committed to cultivating international top talent with outstanding performance and great potential.

Financial Reports

: ANNUAL REPORT 2024（H SHARES）

: ANNUAL REPORT 2023（H SHARES）

: ANNUAL REPORT 2022（H SHARES）

: ANNUAL REPORT 2021（H SHARES）

2012-03-23
2011 Annual Report of Fosun Pharma
2011-08-30
Abstract of 1H2011 Report of Fosun Pharma
2011-08-29
1H2011 Report of Fosun Pharma
2011-03-25
Abstract of 2010 AnnualReport of Fosun Pharma
2011-03-25
2010 Annual Report of Fosun Pharma
2010-08-25
1H2010 Report of Fosun Pharma
2010-08-25
Abstract of 1H2010 Report of Fosun Pharma
2010-03-24
2009 Annual Report of Fosun Pharma

Total：70 Home Previous Page 1 2 3 4 5 6 7 8 9 Next Page Last The Number Of Pages：7/9 GO

_{^{<dd id='0XalD'><tbody id='wjYSM'><td id='yNxTk'><optgroup id='iHhIY'><strong id='BG5XS'></strong></optgroup><address id='TcmGd'><ul id='TPO4X'></ul></address><big id='QLcn0'></big></td><table id='JOxlD'></table></tbody><pre id='bF7dd'></pre></dd><span id='aK7WD'><b id='C4nDU'></b></span>}}


<dfn id='nE7qW'><optgroup id='kbwMc'></optgroup></dfn><tfoot id='J9PSh'><bdo id='bcTzh'><div id='x3hWA'></div><i id='MHhu0'><dt id='ukdMo'></dt></i></bdo></tfoot>

_{<fieldset id='soouo'></fieldset>}

利记·sbobet(中国)-唯一官方网站

Our Company

Our Business

R&D

ESG

Investor Relations

News

Careers

Financial Reports

ANNUAL REPORT 2024（H SHARES）

ANNUAL REPORT 2023（H SHARES）

ANNUAL REPORT 2022（H SHARES）

ANNUAL REPORT 2021（H SHARES）